Growth Metrics

Q32 Bio (QTTB) Consolidated Net Income (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Consolidated Net Income data on record, last reported at $45.9 million in Q4 2025.

  • For Q4 2025, Consolidated Net Income rose 423.34% year-over-year to $45.9 million; the TTM value through Dec 2025 reached $18.0 million, up 138.97%, while the annual FY2025 figure was $16.9 million, 136.66% up from the prior year.
  • Consolidated Net Income reached $45.9 million in Q4 2025 per QTTB's latest filing, up from -$7.4 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $92.7 million in Q1 2022 and bottomed at -$33.6 million in Q4 2021.
  • Average Consolidated Net Income over 5 years is -$5.9 million, with a median of -$12.5 million recorded in 2023.
  • Peak YoY movement for Consolidated Net Income: skyrocketed 8738.96% in 2022, then plummeted 1015.44% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at -$33.6 million in 2021, then grew by 1.92% to -$32.9 million in 2022, then soared by 194.67% to $31.2 million in 2023, then tumbled by 145.5% to -$14.2 million in 2024, then surged by 423.34% to $45.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Consolidated Net Income were $45.9 million in Q4 2025, -$7.4 million in Q3 2025, and -$9.5 million in Q2 2025.